Comparison of fixed tilt and tuned defibrillation waveforms: the PROMISE study

J Cardiovasc Electrophysiol. 2013 Mar;24(3):323-7. doi: 10.1111/jce.12041. Epub 2012 Dec 4.

Abstract

Background: All modern defibrillation systems use biphasic shock waveforms. Typically a fixed tilt waveform is used for implantable defibrillators (ICDs), but a tuned waveform with duration based on shock impedance may be superior based on theoretical calculations.

Objective: The objective of this study was to compare defibrillation efficacy of fixed tilt and tuned waveforms.

Methods: PROMISE was designed as a prospective, within-patient, randomized study of defibrillation thresholds (DFTs) comparing a tuned (assuming a 3.5 milliseconds membrane time constant) versus a 50/50% tilt waveform. All patients had a left pectoral implant (active can) and testing was performed with a single coil shocking configuration ("SVC coil OFF"). DFTs were measured in random order with a binary search method in 52 patients, using the high-voltage lead impedance to select the pulse widths for both waveforms.

Results: At the DFT, the tuned waveform had similar delivered energy (10.5 ± 6.3 vs 9.5 ± 5.5 J, P = 0.47), stored energy (13.6 ± 7.9 vs 11.3 ± 6.3 J, P = 0.06), peak current (7.5 ± 3.0 vs 6.8 ± 2.2 A, P = 0.09), and delivered voltage (451.0 ± 134.5 vs 411.5 ± 120.7 V, P = 0.05) compared with the 50/50% tilt waveform.

Conclusion: The DFTs for 3.5-millisecond time constant based tuned and 50/50% tilt waveforms are similar using a single coil, left pectoral active can.

Trial registration: ClinicalTrials.gov NCT00874445.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Algorithms
  • Defibrillators, Implantable
  • Electric Countershock / instrumentation
  • Electric Countershock / methods*
  • Equipment Design
  • Female
  • Humans
  • Male
  • Materials Testing
  • Middle Aged
  • Prospective Studies
  • Signal Processing, Computer-Assisted
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • United States
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / physiopathology
  • Ventricular Fibrillation / therapy*
  • Ventricular Function, Left

Associated data

  • ClinicalTrials.gov/NCT00874445